Physician profile
Mark S Robertson
NPI 1487679700
$6,701.93
in general payments reported to CMS, 2019-2025
25 companies · $302 in 2025
The $302 reported for 2025 was less than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,049 · 2020: $37.43 · 2021: $499 · 2022: $98.57 · 2023: $327 · 2024: $388 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,017.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $4,950.00 | 2019 | |
| Genzyme Corporation | $392.43 | 2022-2025 | |
| Stryker Corporation | $332.71 | 2021-2023 | Scopis Ent |
| Regeneron Healthcare Solutions, INC. | $191.62 | 2023-2025 | Dupixent |
| Glaxosmithkline, LLC. | $93.88 | 2021-2024 | Nucala |
| Karl Storz Endoscopy-America | $92.03 | 2021-2025 | |
| Intersect Ent, INC. | $86.16 | 2019-2022 | |
| Optinose US, INC. | $63.96 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $61.59 | 2023-2025 | Keytruda |
| Medtronic, INC. | $55.60 | 2023 | Nuvent, Alar |
| Takeda Pharmaceuticals U.S.A., INC. | $50.50 | 2024 | Takhzyro, Cuvitru |
| Kaleo, INC. | $36.11 | 2021 | |
| Acera Surgical, INC. | $34.26 | 2020-2024 | Restrata Wound Matrix |
| Phathom Pharmaceuticals, INC. | $33.34 | 2024 | Voquezna |
| Csl Behring | $32.65 | 2024 | Haegarda |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $28.12 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.87 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $24.25 | 2025 | Neffy |
| Smith+Nephew, INC. | $19.71 | 2019 | |
| Coopersurgical, INC. | $18.12 | 2019 | |
| Livanova USA, INC. | $17.97 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Integra Lifesciences Corporation | $16.82 | 2024 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Genentech USA, INC. | $16.51 | 2023 | Xolair |
| Aerin Medical INC. | $13.02 | 2022 | |
| Alk-Abello, INC | $12.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Robertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.